Avadel can seek to expand Lumryz's label after court ruling

Avadel Pharmaceuticals can try to expand the use of its blockbuster narcolepsy drug after a federal appeals court overturned an order that had barred it from filing for FDA approval for use in idiopathic hypersomnia ...